| Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain J Van Elslande, P Vermeersch, K Vandervoort, T Wawina-Bokalanga, ... Clinical Infectious Diseases 73 (2), 354-356, 2021 | 355 | 2021 |
| Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients J Van Elslande, E Houben, M Depypere, A Brackenier, S Desmet, ... Clinical Microbiology and Infection 26 (8), 1082-1087, 2020 | 291 | 2020 |
| Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs J Van Elslande, B Decru, S Jonckheere, E Van Wijngaerden, E Houben, ... Clinical Microbiology and Infection 26 (11), 1557. e1-1557. e7, 2020 | 146 | 2020 |
| Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection J Van Elslande, M Oyaert, S Ailliet, M Van Ranst, N Lorent, ... Journal of Clinical Virology 136, 104765, 2021 | 139 | 2021 |
| Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers J Van Elslande, L Gruwier, L Godderis, P Vermeersch Clinical Infectious Diseases 73 (12), 2366-2368, 2021 | 65 | 2021 |
| Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection J Van Elslande, M Oyaert, N Lorent, YV Weygaerde, G Van Pottelbergh, ... Diagnostic Microbiology and Infectious Disease 103 (1), 115659, 2022 | 60 | 2022 |
| Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center M Weemaes, S Martens, L Cuypers, J Van Elslande, K Hoet, ... Journal of the American Medical Informatics Association 27 (8), 1293-1299, 2020 | 33 | 2020 |
| IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers B Decru, J Van Elslande, S Steels, G Van Pottelbergh, L Godderis, ... Frontiers in immunology 13, 909910, 2022 | 27 | 2022 |
| The metabolic fingerprint of COVID-19 severity T Dierckx, J Van Elslande, H Salmela, B Decru, E Wauters, J Gunst, ... MedRxiv, 2020.11. 09.20228221, 2020 | 17 | 2020 |
| Transient increase of pre-existing anti-IFN-α2 antibodies induced by SARS-CoV-2 infection S Steels, J Van Elslande, ... Journal of Clinical Immunology 42 (4), 742-745, 2022 | 15 | 2022 |
| Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2 B Decru, J Van Elslande, M Weemaes, E Houben, I Empsen, E André, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (10), e197-e199, 2020 | 12 | 2020 |
| Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020 F Buntinx, P Claes, M Gulikers, J Verbakel, DL Jan, M Van der Elst, ... Acta clinica Belgica 77 (2), 295-300, 2022 | 11 | 2022 |
| UPLC-MS/MS method for determination of retinol and α-tocopherol in serum using a simple sample pretreatment and UniSpray as ionization technique to reduce matrix effects N Peersman, JV Elslande, Y Lepage, S De Amicis, K Desmet, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (5), 769-779, 2020 | 10 | 2020 |
| Comprehensive immunovirological and environmental screening reveals risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks L Cuypers, E Keyaerts, S Hong, S Gorissen, SM Menezes, M Starick, ... | 8 | 2022 |
| Three Cases of Atypical Pneumonia with Chlamydia psittaci: The Role of Laboratory Vigilance in the Diagnosis of Psittacosis S Missault, A De Meyst, J Van Elslande, AM Van den Abeele, E Steen, ... Pathogens 12 (1), 65, 2022 | 6 | 2022 |
| Two separate clusters of SARS-CoV-2 delta variant infections in a group of 41 students travelling from India: an illustration of the need for rigorous testing and quarantine J Van Elslande, F Kerckhofs, L Cuypers, E Wollants, B Potter, ... Viruses 14 (6), 1198, 2022 | 6 | 2022 |
| IgG anti-spike antibody levels in healthcare workers with and without prior COVID-19 up to 3 months after BNT162b2 vaccination J Van Elslande, M Weemaes, L Godderis, G Van Pottelbergh, X Bossuyt, ... Diagnostic Microbiology and Infectious Disease 102 (4), 115638, 2022 | 6 | 2022 |
| The sudden death of the combined first trimester aneuploidy screening, a single centre experience in Belgium J Van Elslande, N Brison, JR Vermeesch, K Devriendt, K Van den Bogaert, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (11), e294-e297, 2019 | 6 | 2019 |
| Immunoassays for anti-SARS-CoV-2 antibodies: Recent insights J Van Elslande, E André, M Van Ranst, K Lagrou, P Vermeersch The Lancet Infectious Diseases 21 (5), e120, 2021 | 5 | 2021 |
| Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1 … X Bossuyt, JB Vulsteke, J Van Elslande, L Boon, G Wuyts, S Willebrords, ... Autoimmunity reviews 22 (4), 103288, 2023 | 4 | 2023 |
